🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity ◆ Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing ◆ Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich ◆ Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery ◆ Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity ◆ Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing ◆ Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich ◆ Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery ◆ Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆
Clinical Trials in Canada / NCT05913687
Active, not recruiting Observational

Automated Imaging Differentiation of Parkinsonism

NCT05913687 · tracked via the Priya Life Science Canada tracker
Sponsor
University of Florida
Phase
Observational
Started
2021-07-22
Last updated
2026-07-31

Condition(s) studied

Parkinson DiseaseMultiple System Atrophy, Parkinson VariantProgressive Supranuclear Palsy

Investigational drug(s) / intervention(s)

AIDP

AIDP: Machine learning algorithm of imaging data

Study summary

The purpose of this study is to test the performance of the AID-P across 21 sites in the Parkinson Study Group. Each site will perform imaging, clinical scales, diagnosis, and will upload the data to the web-based software tool. The clinical diagnosis will be blinded to the diagnostic algorithm and the imaging diagnosis will be compared to the movement disorders trained neurologist diagnosis.

Eligibility

Sex
ALL
Min age
40 Years
Max age
80 Years
Healthy volunteers
No
Inclusion Criteria: * Parkinson's disease diagnosis within 5-9 years of baseline date * MSAp diagnosis * PSP diagnosis Exclusion Criteria: * metal implants in the body that preclude an MRI (pacemaker, metallic clip, neurostimulator, etc) * claustrophobia * pregnancy

Primary outcome measure(s)

Trial sites (21)

FacilityCityRegionStatus
University of Alabama at Birmingham Birmingham Alabama
University of California San Diego La Jolla California
University of California San Francisco San Francisco California
University of Florida Gainesville Florida
University of South Florida Tampa Florida
Augusta University Augusta Georgia
Northwestern University Chicago Illinois
University of Chicago Chicago Illinois
University of Kentucky Lexington Kentucky
Johns Hopkins University Lutherville Maryland
Beth Israel Deaconess Medical Center Boston Massachusetts
Massachusetts General Hospital Charlestown Massachusetts
University of Michigan Ann Arbor Michigan
University of Minnesota Minneapolis Minnesota
Washington University in St. Louis St Louis Missouri
Albany Medical College Albany New York
Duke University Medical Center Durham North Carolina
Wake Forest University Winston-Salem North Carolina
Pennsylvania State University Hershey Pennsylvania
Ottawa Hospital Research Institute Ottawa Canada
Centre for Addiction and Mental Health Toronto Canada

Other trials for the same condition

PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort Recruiting
ExAblate Pallidotomy for Medically-Refractory Dyskinesia Symptoms or Motor Fluctuations of Advanced Parkinson's Disease Active, not recruiting
Exercise to Improve Sleep in Parkinson's Disease Recruiting
Brain-Machine Interface for Freezing of Gait Enrolling by invitation
North American Prodromal Synucleinopathy Consortium Enrolling by invitation
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05913687 on ClinicalTrials.gov ↗ ← All trials in Canada